Advertisement

Recommendations on Blood Recovery in Obstetrics

  • Gerhardt Konig
Chapter

Abstract

Hemorrhage is one of the leading preventable causes of maternal death. The safe use of blood recovery (also referred to as cell salvage) in obstetrics is well established. Blood recovery is the process by which blood is suctioned from the surgical field into a blood recovery device, where the blood is filtered, washed by centrifugation with a saline solution, and then transfused back to the patient. Blood recovery is recommended for elective cesarean sections where there is increased risk of hemorrhage (e.g., placenta previa/accreta, fibroid uterus, history of post-partum hemorrhage, etc.), or significant anemia at time of cesarean section regardless of risk factors for hemorrhage. Blood recovery is also recommended for emergency use in major obstetric hemorrhage from all causes. The safe and effective use of blood recovery requires a dedicated team of trained staff members.

Keywords

Obstetric hemorrhage Blood recovery Cell salvage Transfusion Hemorrhage 

References

  1. 1.
    American College of Obstetricians and Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039–47.CrossRefGoogle Scholar
  2. 2.
    Royal College of Obstetricians and Gynaecologists, editor. Blood transfusion in obstetrics. Green-top guideline no. 47. 2nd ed. London: Royal College of Obstetricians and Gynaecologists; 2015.Google Scholar
  3. 3.
    The Association of Anaesthetists of Great Britain and Ireland. Safety guideline blood transfusion and the anaesthetist intra-operative cell salvage. London: The Association of Anaesthetists of Great Britain and Ireland; 2009.Google Scholar
  4. 4.
    Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth. 1998;80:195–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Grimes DA. A simplified device for intraoperative autotransfusion. Obstet Gynecol. 1988;72:947–50.CrossRefPubMedGoogle Scholar
  6. 6.
    Jackson SH, Lonser RE, et al. Transfusion. 1993;33:181.CrossRefPubMedGoogle Scholar
  7. 7.
    Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth. 2015;24(1):86–7.CrossRefPubMedGoogle Scholar
  8. 8.
    DeAndrade D, Waters JH, Triulzi DJ, Alarcon L, Wisniewski MK, Dyga R, Yazer MH. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion. 2016;56(11):2768–72.CrossRefPubMedGoogle Scholar
  9. 9.
    Bernstein HH, Rosenblatt MA, Gettes M, Lockwood C. The ability of the Haemonetics 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg. 1997;85:831–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Waters JH, Biscotti C, Potter P, Phillipson E. Amniotic fluid removal during cell-salvage in the cesarean section patient. Anesthesiology. 2000;92:1531–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations